InVivoMAb anti-mouse MHC Class I (H-2Kb)

Paschall AV, Zhang R, Qi CF, et al. IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiation. J Immunol. 2015,194(5):2369-79. doi: 10.4049/jimmunol.1402412

Penaloza-MacMaster P, Kamphorst AO, Wieland A, et al. Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection. J Exp Med. 2014,211(9):1905-18. doi: 10.1084/jem.20132577

Kearl TJ, Jing W, Gershan JA, et al. Programmed death receptor-1/programmed death receptor ligand-1 blockade after transient lymphodepletion to treat myeloma. J Immunol. 2013,190(11):5620-8. doi: 10.4049/jimmunol.1202005

Takenaka M, Subramanian V, Tiriveedhi V, et al. Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection. J Heart Lung Transplant. 2012,31(11):1214-22. doi: 10.1016/j.healun.2012.08.011

Shaikh SR, Rockett BD, Salameh M, et al. Docosahexaenoic acid modifies the clustering and size of lipid rafts and the lateral organization and surface expression of MHC class I of EL4 cells. J Nutr. 2009,139(9):1632-9. doi: 10.3945/jn.109.108720